LYCA LYCIA THERAPEUTICS INC
FollowCommon Stock, $0.0001 par value per share (common), issuer CIK 1806540
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Venrock Healthcare Capital Partners III, L.P.(group Venrock Healthcare Capital Partners III, L.P.)
6,850,237 shares, 11.9% in a 13G as of 2026-10-23,0001738048-26-000077
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
Venrock Healthcare Capital Partners III, L.P. and 8 other reporting persons reported 6,850,237 LYCA shares, 11.9% of the class, as of 2026-10-23, in a 13G filed 2026-10-30. 0001738048-26-000077
Accepted , ingested